Journal article
Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease – should one consider disease location? Authors’ reply
Authors
Narula N; Reinisch W
Journal
Alimentary Pharmacology & Therapeutics, Vol. 44, No. 7, pp. 772–773
Publisher
Wiley
Publication Date
October 2016
DOI
10.1111/apt.13768
ISSN
0269-2813